Interestingly, when a VV vector coordinately expressing multiple antigen epitopes and two co-stimulatory molecules B7.1 and B7.2 in the context of systemic GM-CSF was administered to melanoma patients, specific CTLs against melanoma-associated antigens were rapidly induced in vivo [65]. The gene discussed is CD86; the disease is melanoma.